http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101780097-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ad24ee598513de18dc880b70c5b9528 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 |
filingDate | 2010-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb1d7d2f39d85c2387db67155f1799fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b837092844164accaf8d9f09b5aca5b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27bb9c9db10cfbe7a3d9c03390ce8633 |
publicationDate | 2013-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-101780097-B |
titleOfInvention | Application of DGPP (diacylglycerol pyrophosphate) in preparation of medicines for treating ischemic heart disease |
abstract | The invention discloses application of DGPP (diacylglycerol pyrophosphate) in the preparation of medicines for promoting bone marrow stromal cells to secrete VEGF (Vascular Endothelial Growth Factor) and medicines for treating ischemic heart disease and nervous ischemia injury. The DGPP can promote the bone marrow stromal cells to secrete VEGF, facilitate angiogenesis, increase neocapillary density, and greatly improve the treatment effect of bone marrow stromal cells on ischemic heart disease. |
priorityDate | 2010-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.